Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
+569
New +$195K 0.05% 133
2024
Q1
Sell
-371
Closed -$120K 76
2023
Q4
$120K Buy
+371
New +$101K 0.09% 69
2022
Q4
Sell
-110
Closed -$25K 77
2022
Q3
$25K Buy
+110
New +$26.7K 0.01% 145

Other funds holding AMGN

EdgeRock Capital's AMGN Position: Q2 2026 in Review

EdgeRock Capital opened a new position in Amgen (AMGN) in Q2 2026: 569 shares worth $206K. The stake represents 0.05% of the portfolio and ranks #133 among its holdings. This is a return to the name: EdgeRock Capital previously reported a position in AMGN as recently as Q4 2023.

EdgeRock Capital first reported a position in AMGN in Q3 2022 and has held it in 3 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • EdgeRock Capital held 569 shares of Amgen worth $206K as of Q2 2026.
  • Amgen was a new EdgeRock Capital position in Q2 2026.
  • Amgen made up 0.05% of EdgeRock Capital's portfolio in Q2 2026, its #133 holding.
  • EdgeRock Capital first reported a position in Amgen in Q3 2022 and has held it in 3 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on EdgeRock Capital's 13F filing for Q2 2026, filed 24 Jul 2026.